Naltrexone and Buprenorphine Market Set to Reach USD 12.40 Billion by 2034 Amid Rising Opioid Addiction Treatment Demand

Market Overview The global naltrexone and buprenorphine market is experiencing robust growth, projected to rise from USD 4.98 billion in 2024 to USD 12.40 billion by 2034. This expansion reflects a CAGR of 9.6% over the forecast period, highlighting increasing demand for opioid dependence treatment options globally. Naltrexone, an opioid a

read more